This is a StreetInsider.com Premium Only Page

Aratana Therapeutics (PETX) – Press Releases

Oct 9, 2019 08:02 AM iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board

Jul 18, 2019 08:31 AM Elanco Finalizes Acquisition of Aratana Therapeutics

Jul 16, 2019 04:15 PM Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health

Jun 24, 2019 07:00 AM CureVac Welcomes Two Members to its Supervisory Board

Jun 24, 2019 07:00 AM CureVac Welcomes Two Members to its Supervisory Board

Jun 11, 2019 04:05 PM Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial

Jun 7, 2019 04:59 PM Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders

May 8, 2019 04:05 PM Aratana Therapeutics Reports First Quarter 2019 Financial Results

May 7, 2019 08:00 AM Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference

Apr 29, 2019 05:28 PM Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aratana Therapeutics, Inc. (PETX) on Behalf of Stockholders and Encourages PETX Investors to Contact the Firm

Apr 26, 2019 06:29 AM Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus

Apr 26, 2019 06:28 AM Aratana Therapeutics to be Acquired by Elanco Animal Health

Apr 22, 2019 08:30 AM Aratana Therapeutics to Report First Quarter 2019 Financial Results

Mar 12, 2019 04:05 PM Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Feb 13, 2019 08:30 AM Aratana Therapeutics to Participate at Upcoming Investment Conferences

Feb 12, 2019 08:30 AM Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results

Feb 4, 2019 07:45 AM Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer

Jan 17, 2019 08:53 PM Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer

Nov 9, 2018 09:00 AM Factors of Influence in 2018, Key Indicators and Opportunity within EnLink Midstream, Kemper, Aratana Therapeutics, CURO Group, Perficient, and GCP Applied Technologies — New Research Emphasizes Eco

Nov 1, 2018 04:05 PM Aratana Therapeutics Reports Third Quarter 2018 Financial Results

Oct 22, 2018 08:47 AM Aratana Therapeutics to Report Third Quarter 2018 Financial Results

Oct 11, 2018 08:55 AM Report: Exploring Fundamental Drivers Behind Seritage Growth Properties, Forrester Research, Chemours, MoSys, Malibu Boats, and Aratana Therapeutics — New Horizons, Emerging Trends, and Upcoming Dev

Aug 29, 2018 08:30 AM Aratana Therapeutics to Present at CL King and Associates Best Ideas Conference

Aug 2, 2018 04:05 PM Aratana Therapeutics Reports Second Quarter 2018 Financial Results

Jul 10, 2018 08:30 AM Aratana Therapeutics to Report Second Quarter 2018 Financial Results

Jun 1, 2018 08:30 AM Aratana Therapeutics Files for FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) Label Expansion

May 22, 2018 04:05 PM Aratana Therapeutics to Participate at Jefferies 2018 Global Healthcare Conference

May 21, 2018 08:30 AM Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital

May 3, 2018 04:05 PM Aratana Therapeutics Reports First Quarter 2018 Financial Results

Apr 12, 2018 08:30 AM Aratana Therapeutics to Report First Quarter 2018 Financial Results

Apr 5, 2018 09:29 AM Aratana Therapeutics Confirms Receipt of Board Nominations

Mar 13, 2018 04:05 PM Aratana Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

Mar 2, 2018 08:30 AM Aratana Therapeutics to Participate at Upcoming Investment Conferences

Mar 1, 2018 08:30 AM Aratana Therapeutics Expands Therapeutic Candidate Pipeline

Feb 13, 2018 08:30 AM Aratana Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results

Jan 18, 2018 08:00 AM GALLIPRANT® (grapiprant tablets) Named Best Companion Animal Product for 2017

Jan 11, 2018 08:20 AM Elanco, Aratana Announce Marketing Authorization of GALLIPRANT® (grapiprant tablets) in Europe

Dec 20, 2017 08:05 AM Aratana Therapeutics Granted Conditional License for a Canine Osteosarcoma Therapeutic

Dec 15, 2017 04:15 PM Aratana Therapeutics Announces Study Results for AT-016

Nov 28, 2017 06:56 PM Aratana Therapeutics, Inc. Announces Termination of Offering of Common Stock

Nov 27, 2017 04:10 PM Aratana Therapeutics, Inc. Announces Proposed Public Offering

Nov 10, 2017 11:31 AM Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe

Nov 2, 2017 04:05 PM Aratana Therapeutics Reports Third Quarter 2017 Financial Results

Oct 30, 2017 08:30 AM Aratana Therapeutics to Present at Credit Suisse Healthcare Conference

Oct 13, 2017 04:05 PM Aratana Therapeutics Announces Launch of ENTYCE® (capromorelin oral solution)

Oct 5, 2017 04:30 PM Aratana Therapeutics to Report Third Quarter 2017 Financial Results

Sep 18, 2017 08:00 AM Aratana Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference

Aug 3, 2017 04:30 PM Aratana Therapeutics Reports Second Quarter 2017 Financial Results

Jul 26, 2017 08:30 AM Aratana Therapeutics Announces Positive Results for AT-003

Jul 18, 2017 04:30 PM Aratana Therapeutics to Report Second Quarter 2017 Financial Results